Stanislaw Burzynski’s Proven Cancer Cure Attacked by FDA and Texas Board of Medical Examiners

Challenges in Obtaining Treatment Permission in the US

• Patients in the United States face a complex bureaucratic process to get permission for treatment, which often leads to many patients being unable to navigate it successfully.
• The regulations in the U.S. are considered stringent compared to other countries, making it challenging for patients seeking treatment.
• Sergeant Rick Schiff highlights the difficulties he faced in obtaining effective treatment for his daughter in the U.S. due to these bureaucratic hurdles.

“It is very difficult for some reason to obtain permission to treat patients in the United States. I think this country has the finest bureaucratic regulations in the world, and the other countries are way behind here.”

Dr. Burzynski’s Treatment and Success Stories

• Dr. Burzynski’s unconventional cancer treatment, known as antineoplastons, showed promising results in treating patients, with some achieving remission or substantial improvement.
• Rick Schiff’s daughter, who had a highly malignant brain tumor, saw significant positive outcomes after receiving Dr. Burzynski’s treatment.
• Despite initial skepticism, Rick conducted his investigation and became convinced of the effectiveness of Dr. Burzynski’s approach in treating cancer.

“18 months later we took my daughter off the antineoplaston; she had not died. She had no signs of a tumor. Within a month, the cancer was widespread in her brain. We put her back on Burzynski’s, and within nine weeks, the tumor was completely gone.”

Dr. Burzynski’s Legal Battle

• Dr. Burzynski faced challenges from the Texas Board of Medical Examiners, despite patient satisfaction and positive treatment outcomes.
• The Board attempted to force complaints against him and even traveled at taxpayers’ expense to do so.
• Dr. Burzynski had to defend his practices in front of the Board multiple times, presenting cases of patients benefiting from his treatments.
• The Board’s investigations lacked patient complaints and seemed unjustified, leading to a prolonged legal battle.

“This was completely irrational. Patients were benefitting, but the Board persisted in their actions.”

State Board of Medical Examiner’s Actions

• The State Board of Medical Examiners fought to suspend Dr. Burzynski’s license, despite acknowledging that the efficacy of antineoplastons in cancer treatment wasn’t in question in the proceedings.
• Dr. Burzynski won a court battle overturning the medical examiner’s order, but the Texas Medical Board persisted in trying to revoke his license, even involving the Texas State Supreme Court.
• The FDA pressured the Texas Medical Board to continue pursuing the revocation of Dr. Burzynski’s medical license.
• “If efficacy was not an issue and Dr. Burzynski wasn’t breaking any laws, then why would the Texas Medical Board continue this pursuit?”

The efficacy of antineoplastons in cancer treatment wasn’t at issue in the legal proceedings surrounding Dr. Burzynski, prompting questions about the motive behind the relentless pursuit by authorities.

FDA’s Pressure and Legal Battles

• The FDA intensively pressured to revoke Dr. Burzynski’s medical license and even attempted to place him in prison.
• Various threats were made, including raiding his clinic and home under the guise of seizing assets and conducting a propaganda campaign against him.
• Despite the FDA’s threats, a judge allowed Dr. Burzynski to continue treating patients in Texas, though without the ability to ship his medicine across state lines.

The FDA’s aggressive tactics included threats of raiding his property, conducting a propaganda campaign, and potential criminal prosecution as a means to undermine Dr. Burzynski’s work.

Legal Battels and Seizure of Records

• The FDA conducted a raid on Dr. Burzynski’s clinic, seizing 200,000 pieces of paper, including vital medical records, which impeded his ability to continue treating patients effectively.
• Dr. Burzynski struggled for years to recover the seized medical records, compromising patient care and the ability to fight for their lives.
• Despite confiscating records, no indictment was issued, leading to repeated seizures of documents without legal consequences.

The seizure of essential medical records during the raids on Dr. Burzynski’s clinic severely impacted patient care and his ability to fight for the lives of those under his treatment.

FDA’s Actions Towards Dr. Burzynski

• The FDA has not proven the effectiveness of Dr. Burzynski’s treatment through controlled clinical trials.
• While the FDA doesn’t claim the treatment is unsafe or ineffective, they are challenging Dr. Burzynski’s shipping practices, despite approvals granted for the medicine’s distribution.

FDA’s Subpoena Tactics

• The FDA has resorted to subpoenaing medical records of patients who publicly support Dr. Burzynski, escalating their investigation tactics.
• By subpoenaing records from Dr. Burzynski and his associates globally, the FDA aims to hinder his business operations and potentially disrupt his treatment dissemination.

Instead of relying on patient inquiries, the FDA is aggressively subpoenaing records to impede Dr. Burzynski’s treatment practices.

Allegations of FDA Interference

• Concerns are raised about the FDA’s repeated grand jury investigations into Dr. Burzynski, suggesting a potential vendetta or undue harassment by the regulatory body.
• The FDA’s actions, including multiple grand jury investigations without indictments, have led to questions about their intentions and impact on patient access to treatment.

The ongoing grand jury investigations into Dr. Burzynski prompt speculation about the FDA’s motives and their impact on patient care and treatment choices.

Dustin’s Journey with Dr. Burzynski’s Treatment

• Dustin, diagnosed with a malignant brain tumor as a toddler, was initially given little hope with traditional treatments.
• Despite doctors recommending harsh treatments with severe side effects, Dustin’s parents chose to seek alternative options.
• After starting Dr. Burzynski’s treatment, Dustin’s MRI results showed significant improvement within weeks.
• Over time, the tumor almost disappeared, and Dustin, once given a grim prognosis, thrived and outlived expectations.

“An MRI six weeks after we started Dr. Burzynski’s treatment revealed no tumor.”

FDA’s Initiatives for Cancer Drug Approval

• FDA’s new proposals aim to expedite access to effective cancer treatments.
• The focus shifts towards objective evidence of treatment response rather than strictly survival rates.
• The initiatives include faster approval for promising drugs from other countries and involving cancer patients in decision-making processes.
• Reducing unnecessary paperwork and easing research obstacles demonstrate a pivotal change in cancer drug approvals.

“American cancer patients from now on will have faster and easier access to more promising therapies.”

Legal Battle and Support for Dr. Burzynski

• Dr. Burzynski’s legal challenges reveal a profound dispute over the use of his innovative but unapproved treatment.
• The trial, involving significant costs and public attention, is a pivotal moment to determine Burzynski’s standing as a medical figure.
• Support for Burzynski’s legal defense comes from various sources, notably Dr. Julian Whitaker and his dedicated readers.
• The trial’s outcome will decide whether Dr. Burzynski is seen as a fraudulent practitioner or a pioneering medical advocate.

“The trial will then decide whether Burzynski is a fraud or a medical pioneer.”

FDA’s Actions and Public Outrage

• The FDA initially failed to present sufficient evidence against Dr. Burzynski, leading to a mistrial and his acquittal on numerous counts.
• Despite initial acquittals, the FDA persisted with repeated trials, ultimately dropping the majority of charges due to the weakness of their case.
• Public support for Dr. Burzynski increased, with even jurors from the first trial protesting against the FDA’s actions outside the courthouse.
• Patients and supporters rallied against what they perceived as a FDA “witch-hunt” and abuse of power, emphasizing the impact on patients’ well-being.
• Jurors expressed shock at the lack of information presented to them regarding the effectiveness of Dr. Burzynski’s treatment, feeling misled by prosecutors.
• The FDA’s efforts to portray Dr. Burzynski as a criminal began to unravel, leading to public discontent with the agency’s actions.

The FDA’s facade and trying to convince the world that Burzynski was a criminal was completely unraveling. even the jurors who voted not guilty in the first case took time off of work to join the patients’ protest in front of the courthouse during the second case. I am appalled at the Food and Drug Administration in their actions.

Development of Phenyl Acetate and Anti-Cancer Activity

• Finasteride, initially with minimal effectiveness, spurred intrigue while working for Devorah Sumeet, revealing the anti-cancer potential of phenyl acetate compounds and its analogs.
• Devorah Sumeet’s leadership spearheaded the discovery of various biological activities with anti-cancer potential, despite facing patent challenges from Johns Hopkins researchers for these compounds.

People would think, ‘patterns, patterns, patterns, you know that sort of thing.’

National Cancer Institute and Phenyl Acetate Research

• Burzynski observed the National Cancer Institute testing phenyl acetate independently, recognizing its tumor maturation induction efficacy and lack of harmful effects, factors crucial for cancer treatment exploration.
• Despite earlier successes and proof of concept, the National Cancer Institute’s subsequent independent trials failed to replicate Burzynski’s findings due to missing key ingredients and patent hurdles.

Ending in the hideous train wreck he warned them it would.

Hindered Clinical Trials and NCI’s Actions

• Burzynski’s dissatisfaction stemmed from the slow enrollment of patients in government-sponsored antineoplaston trials at Mayo Clinic and Sloan-Kettering Hospital.
• Disputes with the National Cancer Institute escalated as they lowered admission standards against Burzynski’s objections, leading to legal threats and the suspension of recruiting, leaving trials with just eight patients.

The future of these trials rests entirely with the NCI since our primary obligation is to the American public.

Contentious Relationship with National Cancer Institute

• Tensions heightened as the National Cancer Institute barred data sharing with Burzynski and his institute, leading to accusations of misconduct and manipulation of trial admissions.
• Burzynski’s outrage at patient mistreatment and data withholding highlighted the ongoing power struggle between him and the NCI over trial conduct and patient safety.

There must be a reason why you are afraid to provide us with complete copies of medical records.

Pharmacokinetic Data Reveals Discrepancies

• The study compared blood concentrations of patients undergoing treatment with the researcher’s prior studies, revealing substantially lower levels of certain ingredients in the patients’ blood.

Patients had significantly lower levels of certain ingredients in their blood compared to what was observed in previous studies.

Unethical Actions in Clinical Trials

• The unethical actions in clinical trials involved administering lower dosages of key ingredients, which hindered the patients’ chances of responding to treatment. This led to the decision to halt the trials.

“Okay, this was like a criminal act…they knew that these patients had really no chance to respond to any treatment and were essentially left to die.”

Governmental Patent Filings

• The government filed patents for antineoplastons, including allegations of stealing the inventor’s work without his knowledge. This included multiple extended patent filings over several years.

“America filed its most extensive updated antineoplaston patent to date, followed by a series of extended patent filings and copycat patents over the years.”

Challenges by National Cancer Institute and Pharmaceutical Companies

• Dr. Burzynski faced challenges from the National Cancer Institute and pharmaceutical companies aiming to steal his invention. Tactics included financial ruin, imprisonment threats, and collusion with government agencies.

“They attempted to wipe me out financially, imprison me, and attack me from every possible angle to steal my invention.”

Burzynski’s Bravery in the Face of Criticism

• Despite facing criticism and skepticism from the medical community, Dr. Burzynski stands by his approach of using peptides to fight cancer effectively.
• The capitalist mentality in the medical field has led to a smear campaign against Dr. Burzynski, diminishing the significance of his innovative treatments.

“Under the capitalist Sun, there’s nothing sacred, money talks.”

Patient Testimonials Contradict Medical Establishment

• Patients like Jody Gold have experienced miraculous recoveries through Dr. Burzynski’s treatments, refuting claims made by some oncologists.
• Despite negative feedback from traditional doctors, patients’ firsthand success stories highlight the potential benefits of Dr. Burzynski’s methods.

“My oncologist, the radiologist, the MRI guy, and everybody we talked to said he’s a quack, you can’t, you should not do that.”

Challenges Faced by Dr. Burzynski

• Dr. Burzynski’s unwavering dedication to his vision for four decades, despite being labeled derogatory terms, illustrates his resilience and steadfast belief in his ability to save lives.
• The documentary emphasizes the resilience and determination of Dr. Burzynski, who faces immense challenges in promoting his unconventional cancer treatment in the medical community.

“He’s had a vision and a passion and a zeal for 40 odd years, put up with being called everything… because of his firm belief that he could save people’s lives.”

Dr. Ignaz Semmelweis: Handwashing Importance

• Dr. Semmelweis discovered the importance of handwashing in preventing disease transmission between autopsy and delivery rooms.
• Despite urging colleagues to wash their hands, he was ostracized from the medical community and died in an insane asylum.
• The scenario parallels the arrogant reluctance to change in the cancer treatment industry, analogous to Semmelweis’s struggle.

“He was drummed out of the medical profession and he died in an insane asylum.”

Antineoplastons and Dr. Burzynski’s Work

• Dr. Burzynski’s research on antineoplastons and gene therapy has shown promise as a safe and effective cancer treatment.
• Collaborations with Japanese doctors helped gain FDA approval for studies and trials, indicating potential for a new cancer treatment strategy.
• The reluctance to embrace new approaches in cancer treatment is compared to the historic resistance to handwashing in medicine.

“So, if you like sound of ice had a problem, just imagine the problem Dr. Burzynski faces.”

Challenges of Traditional Cancer Treatments

• Conventional treatments like radiation can have severe side effects, compromising quality of life and long-term health.
• The oncologist’s grim prognosis for a brainstem glioma patient highlights the harsh reality faced with traditional treatments.
• Parents faced with difficult treatment decisions grapple with the impact on their child’s development and life quality.

“The thing is with the radiation what it would do to you… all your hair around your ears would be gone never grow back.”

Economic Concerns in Cancer Treatment Innovation

• The fear surrounding FDA approval of antineoplastons is driven by the potential economic impact on traditional cancer treatment modalities.
• The approval of antineoplastons could lead to a decline in reliance on toxic chemotherapy and radiation, affecting the profitability of the cancer industry.
• Special interest groups aim to discredit Dr. Burzynski and his innovation due to the threat it poses to established cancer treatment practices.

“The primary reason that the cancer industry and its regulatory agencies fear the approval of antineoplastons is purely economical.”

Astroturfing Tactics in Discrediting Opposing Views

• Astroturfing involves intentionally introducing confusion by inundating discussions with conflicting information, leading to a dismissal of all details, including the truth.
• Entities engaging in astroturfing attack various sources like news organizations, whistleblowers, politicians, and journalists.
• Astroturfing manipulates facts by overwhelming the audience with contradictory paid-for studies, surveys, and expert opinions.
• Examples include linking unrelated issues like vaccines and autism to sow doubt by using conflicting information.
• Wikipedia, despite its open-edit platform, is susceptible to astroturfing, with anonymous editors controlling pages to push specific agendas.

“Astroturfers seek to controversialize those who disagree with them. They attack news organizations that publish stories they don’t like, whistleblowers who tell the truth, politicians who dare to ask the tough questions, and journalists who have the audacity to report on all of it.”

Deception on Wikipedia and Editorial Control

• Anonymous Wikipedia editors manipulate pages to serve vested interests, ignoring the platform’s guidelines in favor of their agenda.
• Editors forbid, reverse, skew, and delete information in violation of established Wikipedia policies.
• The public misconception of being able to freely edit Wikipedia is contradicted by cases where edits are reverted by entrenched editors.
• Not even respected figures like Philip Roth were exempt from editors imposing false information on Wikipedia entries, undermining credibility.
• Wikipedia’s integrity is further tarnished by editors offering PR services to distort information for paying clients.

“Anonymous Wikipedia editors control and co-opt pages on behalf of special interests, forbid and reverse edits that go against their agenda, and skew and delete information in blatant violation of Wikipedia’s own established policies with impunity.”

Hannah’s Miracle Recovery

• Dr. Burzynski’s treatment saved Hannah’s life, defying skeptics who labeled him various negative terms like a fraud or charlatan.
• Despite facing criticism and legal battles, Dr. Burzynski remains dedicated to his work, acknowledging that recognition may only come posthumously.
• The couple expresses gratitude for the treatment that enabled Hannah’s miraculous recovery, highlighting the challenge of addressing widespread misconceptions and hatred towards Dr. Burzynski.

“Dr. Burzynski’s treatment saved her life… People can think what they want… One thing in life you should always try and respect the beliefs that other people have.”

Experiencing Gratitude and Debt of Help

• The couple conveys immense gratitude towards Eric Merola for bringing Dr. Burzynski’s treatment to their attention.
• Hannah’s husband feels a significant responsibility to support others seeking advice on brain tumors since experiencing the successful treatment firsthand.
• They acknowledge that while the treatment may not work for everyone, it has been life-changing for many patients, including Hannah.

“I want to say a massive thank you… They went to great lengths to help us… This treatment didn’t work for everyone but it definitely worked for some people.”

Struggles Against Regulatory Hurdles

• Dr. Burzynski’s clinic faced severe regulatory challenges and prolonged inspections, hampering their progress despite successful clinical trials.
• The continued legal battles led by organizations like the Texas Medical Board aimed to shut down the clinic, jeopardizing potential cancer treatments and final drug approvals.
• Despite positive results from clinical trials, various agencies subjected the clinic to audits and litigations, hindering their efforts to advance cancer treatment options.

“We are furiously attacked by the Texas Medical Board… Simply that action is aimed to destroy our activities… They don’t want to have a cure for cancer.”

Opposing Forces in Cancer Treatment

• The documentary highlights the complex landscape of the cancer industry, where alternative therapies face resistance from established medical institutions.
• Patients share stories of survival and gratitude towards treatments like Dr. Burzynski’s, portraying a stark contrast to conventional cancer treatments.
• The documentary sheds light on the challenges faced by pioneers in alternative medicine, portraying a struggle against a system resistant to change.

“It’s almost like a cancer industrial complex now… I can’t sit back and allow that to happen.”

Stand Against Cancer Cover-Up

• Many people are needed to stand up against the cancer cure cover-up as it is a saddening situation that requires awareness and action; without everyone’s support, the situation won’t improve.
• Doctors, like Dr. Burzynski, have risked their lives and careers to stand up for what is right against the injustices in cancer treatment.
• It is crucial for people to speak up, support these doctors, uncover the truth, and boldly confront the issue to help patients and prevent further harm.

“I believe they should be exposed to some type of investigation to find out why they did it and why they purposely blindly follow the orders of the people who are behind and who told them to destroy us.”

Personal Testimonies and Support for Dr. Burzynski

• Patients express gratitude towards Dr. Burzynski for saving lives and providing hope when conventional medicine failed.
• Advocates emphasize the importance of freedom in medical choices and the right to seek alternative treatments that have proven effective, like those offered by Dr. Burzynski.
• The success stories of patients illustrate the tangible impact of Dr. Burzynski’s treatments in improving health outcomes and extending lives significantly.

“I feel like I owe it to show people that what he does is not quackery. I mean, I was given two months to live, and here I am seven years later, and I’m totally fine.”